# Orrstown Financial Services Inc: financial statements, quarterly

ORRF · Nasdaq · CIK 826154 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/orrf.md) · [Financials](/companies/orrf/financials.md) · [Filings](/companies/orrf/filings.md) · [Insiders](/companies/orrf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/orrf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [12.5](/filings/0000826154-23-000145.md) | [14.0 d](/filings/0000826154-24-000060.md) | [15.8](/filings/0000826154-24-000096.md) | [17.2](/filings/0000826154-24-000191.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.5](/filings/0000826154-24-000223.md) | [2.1 d](/filings/0001628280-26-017278.md) | [2.2](/filings/0000826154-25-000132.md) | [2.1](/filings/0000826154-25-000179.md) | [(2.0)](/filings/0001628280-25-049898.md) | [3.5 d](/filings/0001628280-26-017278.md) | [4.7](/filings/0001628280-26-032835.md) | [5.3](/filings/0001628280-26-054267.md) | [5.8](/filings/0001628280-25-049898.md) | [6.0 d](/filings/0001628280-26-017278.md) | [5.7](/filings/0001628280-26-032835.md) | [3.5](/filings/0001628280-26-054267.md) |
| Net income | $m | [9.0](/filings/0000826154-24-000223.md) | [7.6 d](/filings/0001628280-26-017278.md) | [8.5](/filings/0000826154-25-000132.md) | [7.7](/filings/0000826154-25-000179.md) | [(7.9)](/filings/0001628280-25-049898.md) | [13.7 d](/filings/0001628280-26-017278.md) | [18.1](/filings/0001628280-26-032835.md) | [19.4](/filings/0001628280-26-054267.md) | [21.9](/filings/0001628280-25-049898.md) | [21.5 d](/filings/0001628280-26-017278.md) | [21.8](/filings/0001628280-26-032835.md) | [21.2](/filings/0001628280-26-054267.md) |
| Diluted EPS | $ per share | [0.87](/filings/0000826154-24-000223.md) | not reported | [0.81](/filings/0000826154-25-000132.md) | [0.73](/filings/0000826154-25-000179.md) | [(0.41)](/filings/0001628280-25-049898.md) | not reported | [0.93](/filings/0001628280-26-032835.md) | [1.01](/filings/0001628280-26-054267.md) | [1.13](/filings/0001628280-25-049898.md) | not reported | [1.12](/filings/0001628280-26-032835.md) | [1.09](/filings/0001628280-26-054267.md) |
| Basic EPS | $ per share | [0.87](/filings/0000826154-24-000223.md) | not reported | [0.82](/filings/0000826154-25-000132.md) | [0.74](/filings/0000826154-25-000179.md) | [(0.41)](/filings/0001628280-25-049898.md) | not reported | [0.94](/filings/0001628280-26-032835.md) | [1.01](/filings/0001628280-26-054267.md) | [1.14](/filings/0001628280-25-049898.md) | not reported | [1.13](/filings/0001628280-26-032835.md) | [1.10](/filings/0001628280-26-054267.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [3,054](/filings/0000826154-23-000145.md) | [3,064](/filings/0000826154-25-000090.md) | [3,183](/filings/0000826154-24-000096.md) | [3,199](/filings/0000826154-24-000191.md) | [5,471](/filings/0000826154-24-000223.md) | [5,442](/filings/0001628280-26-017278.md) | [5,442](/filings/0000826154-25-000132.md) | [5,388](/filings/0000826154-25-000179.md) | [5,470](/filings/0001628280-25-049898.md) | [5,542](/filings/0001628280-26-054267.md) | [5,577](/filings/0001628280-26-032835.md) | [5,612](/filings/0001628280-26-054267.md) |
| Total liabilities | $m | [2,811](/filings/0000826154-23-000145.md) | [2,799](/filings/0000826154-25-000090.md) | [2,912](/filings/0000826154-24-000096.md) | [2,920](/filings/0000826154-24-000191.md) | [4,954](/filings/0000826154-24-000223.md) | [4,925](/filings/0001628280-26-017278.md) | [4,909](/filings/0000826154-25-000132.md) | [4,839](/filings/0000826154-25-000179.md) | [4,898](/filings/0001628280-25-049898.md) | [4,951](/filings/0001628280-26-054267.md) | [4,974](/filings/0001628280-26-032835.md) | [4,991](/filings/0001628280-26-054267.md) |
| Long-term debt | $m | not reported | [40.0](/filings/0000826154-24-000060.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [243](/filings/0000826154-24-000223.md) | [265](/filings/0001628280-26-017278.md) | [272](/filings/0000826154-25-000179.md) | [278](/filings/0001628280-25-049898.md) | [516](/filings/0001628280-25-049898.md) | [517](/filings/0001628280-26-054267.md) | [533](/filings/0001628280-26-054267.md) | [548](/filings/0001628280-26-054267.md) | [572](/filings/0001628280-25-049898.md) | [592](/filings/0001628280-26-054267.md) | [603](/filings/0001628280-26-054267.md) | [622](/filings/0001628280-26-054267.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.3 d](/filings/0000826154-24-000223.md) | [13.7 d](/filings/0001628280-26-017278.md) | [12.7](/filings/0000826154-25-000132.md) | [6.4 d](/filings/0000826154-25-000179.md) | [7.5 d](/filings/0001628280-25-049898.md) | [8.4 d](/filings/0001628280-26-017278.md) | [11.0](/filings/0001628280-26-032835.md) | [24.5 d](/filings/0001628280-26-054267.md) | [22.8 d](/filings/0001628280-25-049898.md) | [16.5 d](/filings/0001628280-26-017278.md) | [25.5](/filings/0001628280-26-032835.md) | [22.9 d](/filings/0001628280-26-054267.md) |
| Capital expenditure | $m | [0.3 d](/filings/0000826154-24-000223.md) | [0.5 d](/filings/0001628280-26-017278.md) | [0.1](/filings/0000826154-25-000132.md) | [0.0 d](/filings/0000826154-25-000179.md) | [0.4 d](/filings/0001628280-25-049898.md) | [1.1 d](/filings/0001628280-26-017278.md) | [2.3](/filings/0001628280-26-032835.md) | [0.8 d](/filings/0001628280-26-054267.md) | [0.5 d](/filings/0001628280-25-049898.md) | [0.6 d](/filings/0001628280-26-017278.md) | [0.4](/filings/0001628280-26-032835.md) | [0.5 d](/filings/0001628280-26-054267.md) |
| Dividends paid | $m | [2.1 d](/filings/0000826154-24-000223.md) | [2.1 d](/filings/0001628280-26-017278.md) | [2.1](/filings/0000826154-25-000132.md) | [2.1 d](/filings/0000826154-25-000179.md) | [4.5 d](/filings/0001628280-25-049898.md) | [4.5 d](/filings/0001628280-26-017278.md) | [5.0](/filings/0001628280-26-032835.md) | [5.1 d](/filings/0001628280-26-054267.md) | [5.3 d](/filings/0001628280-25-049898.md) | [5.3 d](/filings/0001628280-26-017278.md) | [5.9](/filings/0001628280-26-032835.md) | [5.9 d](/filings/0001628280-26-054267.md) |
| Share repurchases | $m | [0.0 d](/filings/0000826154-24-000223.md) | [0.0 d](/filings/0001628280-26-017278.md) | [0.0](/filings/0000826154-24-000096.md) | [0.0 d](/filings/0000826154-25-000179.md) | [0.0 d](/filings/0001628280-25-049898.md) | [0.0 d](/filings/0001628280-26-017278.md) | [0.0](/filings/0001628280-26-032835.md) | [0.1 d](/filings/0001628280-26-054267.md) | [0.0 d](/filings/0001628280-25-049898.md) | [0.2 d](/filings/0001628280-26-017278.md) | [0.4](/filings/0001628280-26-032835.md) | [0.0 d](/filings/0001628280-26-054267.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.4](/filings/0000826154-23-000145.md) | [10.5](/filings/0000826154-24-000096.md) | [10.4](/filings/0000826154-24-000191.md) | [10.4](/filings/0000826154-24-000223.md) | [10.5](/filings/0000826154-25-000132.md) | [10.6](/filings/0000826154-25-000179.md) | [19.2](/filings/0001628280-25-049898.md) | [19.3](/filings/0001628280-26-032835.md) | [19.3](/filings/0001628280-26-054267.md) | [19.4](/filings/0001628280-25-049898.md) | [19.4](/filings/0001628280-26-032835.md) | [19.4](/filings/0001628280-26-054267.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,669,626 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054267.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.